IOL Chemicals to Host Analyst Call on Feb 12 for Q3 & 9M FY26 Results
IOL Chemicals and Pharmaceuticals Limited will hold an analyst/investor conference call on February 12, 2026, at 3:00 PM IST. The call will discuss the company's financial performance for Q3 and 9M FY26, ending December 31, 2025. Key management will participate in the discussion.
This is a standard disclosure of a scheduled investor call. The actual impact will depend on the information presented during the call, which is not yet available.
The announcement is a routine disclosure about a scheduled conference call to discuss financial results. It does not contain any new financial performance data or forward-looking statements that would indicate a positive or negative sentiment.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has announced the schedule for an analyst and investor conference call to discuss its financial performance for the third quarter and nine months ended December 31, 2025.
The conference call is scheduled to take place on Thursday, February 12, 2026, at 3:00 PM IST.
The call will feature key management personnel, including Mr. Pardeep Kumar Khanna (Chief Financial Officer), Mr. Abhay Raj Singh (Sr. VP & Company Secretary), Mr. Kushal Kumar Rana (Director Works), and Mr. Rakesh Mahajan (Advisor). Investors and analysts can pre-register for the call using the provided link. Dial-in numbers for India, Hong Kong, Singapore, USA, and UK have also been shared. For RSVP and further inquiries, Ms. Prachi Ambre from MUFG Intime India Pvt. Ltd. can be contacted.
What to do with a filing like this
IOL Chemicals and Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under concall scheduled. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by IOL Chemicals and Pharmaceuticals Limited. Read the original for the full detail.